Back to 
GLENMEDE TRUST CO NA
GLENMEDE TRUST CO NA
NTLA
Showing 0 of 17 quarters
Position history for GLENMEDE TRUST CO NA's holdings in INTELLIA THERAPEUTICS INC
No. Glenmede Trust exited its NTLA (Intellia Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 4,406 shares worth $246,000. Glenmede Trust first reported NTLA in Q4 2018 and held it in 15 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.